KIE Director Dr. Daniel Sulmasy recently joined Georgetown University President John DeGioia in a conversation as part of the Georgetown Now series about ongoing scholarly work and COVID-19
KIE Senior Research Scholar Joel Michael Reynolds Launches New Journal on the Philosophy of Disability
Our scholars are working with other leading experts to help provide ethical guidance in high-level healthcare policies and in day-to-day life during the COVID-19 pandemic. A sample of their direct public engagement can be found here.
KIE Senior Research Scholar Henry S. Richardson partnered with a global group of experts in co-authoring a new paper in Science entitled “An ethical framework for global vaccine allocation.”
KIE Senior Research Scholar Maggie Little last week presented new ethics guidance at AIDS 2020 on behalf of the Pregnancy and HIV/AIDS: Seeking Equitable Study (PHASES) Working Group. The Guidance represents the culmination of a seven-year, NIH-funded project
Read KIE Acting Director Dr. Daniel Sulmasy’s statement on Race, Trust, and Biomedical Ethics
Our webinar turns the focus of discussion toward concerns raised by the COVID-19 / new corona virus pandemic for the people outside the Global North.
Dr. Quill R. Kukla, Senior Research Scholar at The Kennedy Institute of Ethics and Professor of Philosophy at Georgetown University, is one of 2019’s awardees of the Humboldt Research Award.
KIE Senior Research Scholars Madison Powers and Ruth Faden recently published Structural Injustice: Power, Advantage, and Human Rights through the Oxford University Press. Powers and Faden identify structural injustice and present a well-being account that assesses systematic patterns of unfairness. Their theory explains the interconnectedness of human rights violations, advantage, and unfair power patterns. Learn […]
KIE Acting Director and Andre Hellegers Professor of Biomedical Ethics Dr. Daniel Sulmasy and Rose F. Kennedy Professor of Christian Ethics John Keown both responded to new efforts to change assisted dying laws. In the United States, the state of New Jersey recently enacted an Aid-in-Dying law where clinicians can prescribe pills to terminally ill patients. […]
KIE Senior Research Scholar John Keown recently published the 2nd edition of his book Euthanasia, Ethics, and Public Policy: An Argument against Legalisation. In a review of Prof. Keown’s book, Charles Foster, barrister at Serjeants’ Inn Chambers, and a Fellow of Green Templeton College, University of Oxford, describes Keown’s book as “A meticulous, highly readable, and profoundly disturbing […]
KIE Acting Director Dr. Daniel Sulmasy responds to the World Health Organization’s call for setting ethics guidance in gene editing. Read his full comments here.
KIE Acting Director Dr. Daniel Sulmasy voices concern about human genetic editing claimed by Chinese scientist. Reports say that a Chinese scientist claims to have performed genetic editing to create twins girls who are resistant to HIV, the virus that causes AIDS. If this is the case, then it would be the first instance of humans […]
Senior Scholar John Keown will be contributing to the Vatican’s International Congress on Palliative Care, to be held Feb. 28 – March 1 in Rome.
Senior Scholars John Keown and Daniel Sulmasy each spoke at a National Academies of Sciences, Engineering, and Medicine Workshop on Physician-Assisted Death in February.
KIE Director Maggie Little recently spoke in a webinar on the ethical considerations for conducting research with pregnant and lactating women.
Two Senior Research Scholars, John Keown and Daniel Sulmasy, have received the high honor of being inducted as Ordinary Members of the Pontifical Academy for Life (Pontificia Academia Pro Vita).
Marisha Wickremsinhe, KIE research associate and digital campaign coordinator, published an article in the International Journal of Law and Psychiatry. The paper, titled Emergency involuntary treatment law for people with mental disorders: A comparative analysis of legislation in LMICs, compares legislation for emergency involuntary treatment of individuals with mental disorders in low and middle income countries.